Summary:
A Phase 3, Multicenter, Randomized, Double-blind Study of a Single Dose of S-033188 Compared with Placebo or Oseltamivir 75 mg Twice Daily for 5 Days in Otherwise Healthy Patients with Influenza
Qualified Participants Must:
• Be between 12 and 64 years of age
•
Have a fever, headache, feverishness or chills, muscle or joint pain, and/or fatigue
Qualified Participants May Receive:
Free study medication, free physical exams, and compensation per visit